Cart
sales@molnova.com
Mc-Val-Ala-PAB
CAS No. 1870916-87-2
Mc-Val-Ala-PAB( Mc-Val-Ala-PAB, Mc-Val-Ala-PAB-OH | ACD linker )
Catalog No. M18159 CAS No. 1870916-87-2
Mc-Val-Ala-PAB, an effective linker, is utilized in antibody-drug-conjugate (ADC).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 37 | In Stock |
|
| 25MG | 55 | In Stock |
|
| 50MG | 87 | In Stock |
|
| 100MG | 141 | In Stock |
|
| 200MG | 212 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMc-Val-Ala-PAB
-
NoteResearch use only, not for human use.
-
Brief DescriptionMc-Val-Ala-PAB, an effective linker, is utilized in antibody-drug-conjugate (ADC).
-
DescriptionMc-Val-Ala-PAB is a useful linker to make antibody-drug-conjugate (ADC) for targeting drug delivery.
-
In VitroADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
-
In Vivo——
-
SynonymsMc-Val-Ala-PAB, Mc-Val-Ala-PAB-OH | ACD linker
-
PathwayOthers
-
TargetOther Targets
-
RecptorADCs Linker
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1870916-87-2
-
Formula Weight486.57
-
Molecular FormulaC25H34N4O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N[C@@H](C(C)C)C(N[C@@H](C)C(NC(C=C1)=CC=C1CO)=O)=O)CCCCCN2C(C=CC2=O)=O
-
Chemical Name6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-(hydroxymethyl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
MKC9989
MKC9989 is an inhibitor of Hydroxy aryl aldehydes (HAA). MKC9989 also inhibits IRE1α with an IC50 of 0.23 to 44 μM.
-
OD1
Potent rat Nav1.7, human Nav1.4 and rat Nav1.6 channel activator (EC50 values are 7, 10 and 47 nM, respectively). Exhibits minimal activation at mammalian Nav1.2, Nav1.3 and Nav1.5 (EC50 values >3 μM). Inhibits fast inactivation on all channels. Increases peak currents at all voltages and stimulates a persistent Na+ current at hNav1.7 channel. Increases hyperpolarization at Nav1.4 and Nav1.6 channels. Induces spontaneous pain in vivo.
-
Nemorubicin
Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?
